Vaccines Effective Against Indian Variant Of COVID-19: WHO

The variant first identified in India has been classified as a variant of global concern, with some preliminary studies showing that it spreads more easily, a senior WHO official informed on Monday.

The World Health Organisation (WHO) on Tuesday said that the vaccines, therapeutics and diagnostics "continue to be effective" against the B.1.617 variant of COVID-19. "Based on what WHO knows so far as per discussions with experts globally, vaccines, therapeutics and diagnostics continue to be effective against B.1.617 variant (of COVID-19), which WHO has classified as a variant of concern," said WHO Representative to India Dr Roderico H Ofrin. The variant first identified in India has been classified as a variant of global concern, with some preliminary studies showing that it spreads more easily, a senior WHO official informed on Monday. The B.1.617 of the Covid-19 is the fourth variant to be designated as one of global concern that requires more tracking and analysis. The three others strains were first detected in the United Kingdom, South Africa and Brazil.